SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention for its breakout ahead of the expected Q3 earnings report, with traders focused on BRIUMVIs growth and possible further upside. Buyout and short-squeeze chatter is prominent but speculative; some traders instead attribute the move to earnings expectations and the companys commercial momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS REGAL Phase 3 leukemia trial reached its prespecified event threshold, triggering final analysis and putting the GPS survival readout in focus. Traders are sharply divided over whether GPS will show a benefit or whether control-arm outcomes and trial assumptions could undermine the bull case, amid volatile trading and speculation about short positioning.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,396.41. The last known price of BNB is 698.79071116 USD and is down -6.08 over the last 24 hours. It is currently trading on 3523 active market(s) with $4,017,835,584.29 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

Binances reported large-scale security breach and temporary suspension of deposits and withdrawals dominate discussion, with traders worried about exchange security, customer withdrawals, and possible broader crypto-market fallout. Some expect deeper losses or an FTX-like crisis, while others argue Binance can cover customer losses and that the sell-off has been limited.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, fueled by Eylea HD sales and higher Sanofi collaboration revenue from Dupixent, drove a sharp share-price jump and breakout discussion. Traders largely welcomed the results, while some debated whether newer drugs can sustain growth; the upcoming cemdisiran decision also drew attention.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silvers sharp selloff, amid inflation concerns and expectations of higher interest rates, is driving attention to SLV. Traders are split between calling the decline an oversold buying opportunity and warning that selling may continue, with some blaming market manipulation without evidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nintendo, Sony Stocks Move Lower: Can The US-Iran Conflict Hurt Electronic Shipments?

Equity

Nintendo stock declined nearly 3% while Sony shares fell over 1%.


Amazon Missed Out On Nintendo Switch 2's Debut Due To Disagreement Over Unauthorized Sales - Report

The gaming console went on sale in the U.S. at Walmart, Target, Best Buy, and GameStop.


Nintendo Co., Ltd. engages in the development, manufacture, and sale of home entertainment products. Its entertainment products include portable and console game machines and software, trump cards and Karuta (Japanese-style playing cards), multinational consumer electronics, home console hardware such as Nintendo Wii, Nintendo DS, Nintendo 3DS, as well as software for handheld and home console gaming machines. The company was founded by Fusajiro Yamauchi on September 23, 1889 and is headquartered in Kyoto, Japan.

Nintendo Co. Ltd

Bullish Sentiment

<ul class="summary-bullets"><li>The escalating war between the U.S. and Iran has led to oil tankers skipping the Strait of Hormuz and the closure of some of the busiest airports in the Middle East.</li><li>Nintendo and Sony are among some of the biggest electronics producers from Japan, with their products sold globally.</li><li>Stocktwits sentiment for Nintendo was ‘neutral’ as of early Monday.</li></ul>Shares of electronics giants Nintendo and Sony Group declined in Japan on Monday, signaling a rise in investor concerns that the U.S.-Iran conflict, which is leading to the likely closure of the Strait Hormuz, would clog up logistics routes and hurt shipments to Europe and North America.Nintendo shares declined 2.8%, and Sony shares declined 1.4% on the Tokyo Stock Exchange.&nbsp;<h2 class="st-heading-2">Impact Of The US-Iran Conflict</h2>Over the weekend, the U.S.&nbsp;struck targets in Iran and killed its Supreme Leader, Ayatollah Ali Khamenei. Bombardments from both sides have struck neighbouring countries Kuwait, Bahrain, Qatar, and the United Arab Emirates, even as U.S. President Donald Trump has vowed to keep up the offensive if his demands are not met.Several tanker owners have suspended crude oil and natural gas shipments via the Strait of Hormuz, Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/energy/oil-gas-majors-traders-suspend-shipments-via-hormuz-us-attacks-iran-sources-say-2026-02-28/">reported</a>. Meanwhile, thousands of flights were cancelled as war kept major Middle Eastern airports, including Dubai, the world's busiest international hub, as well as key transit airports, including Abu Dhabi in the UAE and Doha in Qatar, severely restricted.U.S. futures&nbsp;dipped about 1%&nbsp;early Monday, and Asian stocks fell sharply. Hong Kong’s&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/baba-bidu-jd-to-dip-in-new-york-today-hang-seng-sinks-as-us-iran-conflict-rattles-chinese-tech/cZddCXYRIcV">Hang Seng fell</a> to its lowest level in the new year.On Stocktwits, retail sentiment was ‘neutral’ for Nintendo’s U.S.-listed shares and Sony’s U.S.&nbsp;stock.<h2 class="st-heading-2">Switch 2 Sales At Risk</h2>For Nintendo, the latest conflict risks disrupting the supply for its Switch 2 gaming unit. The console, launched last June, broke records and pushed the company’s shares to a record high last year.This comes on the heels of Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/sustainable-finance-reporting/nintendo-plans-around-19-billion-share-sale-by-kyoto-bank-others-sources-say-2026-02-27/">reporting</a> on Friday that shareholders MUFG Bank and the Bank of Kyoto were selling about $1.9 billion Nintendo stock back to the company.&nbsp;The move is rising from regulators and the Tokyo Stock Exchange asking companies based in Japan to unwind cross-shareholdings, and the banks have outlined policies to reduce their stakes.U.S.-listed shares of Nintendo are down 16.4% and Sony stock has fallen 10.7% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Nintendo Switch 2 on display inside an electronics store in Yokohama

Nintendo stock declined nearly 3% while Sony shares fell over 1%. Nintendo and Sony are among some of the biggest electronics producers from Japan, with their products sold globally.

Nintendo Co., Ltd.

Nintendo Co. Ltd - ADR

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$52.46
Prev Close	$53.00
Open	$53.00
Dividend Yield	2.63%
50-Day Moving Average	$53.16
Beta	0.60
Avg. Volume	4,203.33
PE Ratio	19.98

52-Week High	$93.61
52-Week Low	$38.34
Market Capitalization	$61.1B
EPS (Annual)	$2.42
Price to Book	3.40
Revenue Per Employee	$1.77M

Feed

News

Sentiment

Earnings

Fundamentals

Info

NTDOF Fundamentals